XenoTherapeutics Corp
Biotechnology company · Enfield, New Hampshire, United States
XenoTherapeutics Corp is a biotechnology company headquartered in Enfield, New Hampshire, United States. Its earliest recorded incorporation is in 2019. It has reported private securities offerings to the US SEC, most recently $1.3 million sold in a notice filed in 2021.
XenoTherapeutics at a glance
What does XenoTherapeutics do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $1.3 million sold (2021).
Frequently asked questions about XenoTherapeutics
Where is XenoTherapeutics headquartered?
XenoTherapeutics Corp is headquartered in Enfield, New Hampshire, United States.
What does XenoTherapeutics do?
XenoTherapeutics Corp is a biotechnology company.
When was XenoTherapeutics founded?
The earliest incorporation on record for XenoTherapeutics Corp is in 2019, according to public company registers.
Similar companies
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
- Vaxcyte, Inc.San Carlos, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences